Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:23 Feb 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1182.75 [ -2.05% ]TCS 2481.80 [ +2.92% ]

Sensex28892.97
28.26 0.10%

Nifty8939.50
12.60 0.14%

Midcap13532.11
25.18 0.19%

Smallcap13587.78
14.75 0.11%


Bse Corporate Announcements Back
Pharma Announces Positive Results of Two Pivotal Phase-3 Clinical Trials of Tildrakizumab
Sun Pharma announced that two pivotal Phase-3 clinical trials evaluating the efficacy and safety of the investigational IL-23p19 inhibitor antibody tildrakizumab (MK-3222) in patients with moderate-to-severe plaque psoriasis met their primary endpoints for both evaluated doses.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com